Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A person must sign a consent form agreeing to take part in the trial.
- Participants must be 18 years of age or older.
- Participants must be willing and able to follow the study's requirements for its full duration, including attending visits, completing examinations, and providing data and samples.
- Participants must have been diagnosed with multiple sclerosis (MS) according to recognised diagnostic guidelines (2017 or 2024 McDonald criteria), covering all forms of the condition, AND either be in the early stages of the disease (diagnosed within the last 3 years), or be attending hospital because their MS has worsened or their treatment needs to change, or be at a stage where their MS appears to be shifting toward a progressive form (as assessed by a doctor using a standard disability scale).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose MS diagnosis is uncertain or who do not meet the above diagnostic requirements may not be eligible.
- People who have a condition — including a mental disability — that could make it difficult or impossible to follow the study procedures, attend visits, or complete questionnaires may not be eligible.
- People who are not fluent in French, English, or German may not be eligible.
- People with a known pregnancy at the time of joining the trial may not be eligible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Krüger Rejko, Prof. Dr. MD, LIH
Phone: 352 26970-265
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Identification of Clinical, Imaging, and Omics Signatures for MS Subtype Stratification
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.